Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Emcure Pharmaceuticals Limited (Emcure) is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals.
Source: Wikipedia
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #20 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 25 Jun 2026 | MORGAN STANLEY ASIA SINGAPORE PTE | Block | Buy | 137,590 | 1817.0000 | NSE |
| 25 Jun 2026 | HSBC MUTUAL FUND | Block | Buy | 137,590 | 1817.0000 | NSE |
| 25 Jun 2026 | HDFC STANDARD LIFE INSURNACE | Block | Buy | 157,949 | 1817.0000 | NSE |
| 25 Jun 2026 | HDFC STANDARD LIFE INSURANCE COMPANY LTD | Block | Buy | 556,954 | 1817.0000 | NSE |
| 25 Jun 2026 | GOLDMAN SACHS INVESTMENTS MAURITIUS I LIMITED | Block | Buy | 137,590 | 1817.0000 | NSE |
| 25 Jun 2026 | BNP PARIBAS FINANCIAL MARKETS | Block | Buy | 137,592 | 1817.0000 | NSE |
| 25 Jun 2026 | BC INVESTMENTS IV LIMITED | Block | Sell | 969,730 | 1817.0000 | NSE |
| 25 Jun 2026 | BC INVESTMENTS IV LIMITED | Block | Sell | 969,729 | 1817.0000 | NSE |
| 25 Jun 2026 | AXIS MUTUAL FUND | Block | Buy | 137,590 | 1817.0000 | NSE |
| 25 Jun 2026 | AXIS MUTUAL FUND | Block | Buy | 137,591 | 1817.0000 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| — | Final Dividend - Rs. - 3.6000 | — | — |
| 4 Sep 2026 | Dividend - Rs 3.60 Per Share | 3.6000 | 4 Sep 2026 |
| 14 Aug 2025 | Dividend - Rs 3 Per Share | 3.0000 | 14 Aug 2025 |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 6 Aug 2026 | Financial Results | Yes |
| 5 May 2026 | Financial Results/Dividend | Yes |
| 4 Feb 2026 | Financial Results | Yes |
| 11 Nov 2025 | Financial Results | Yes |
| 7 Aug 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
